G1 Therapeutics, Inc. (27)

Browse by Contract Category

Contracts

G1 Therapeutics, Inc. Amended and Restated 2021 Inducement Equity Incentive Plan (Filed With SEC on May 4, 2022)
Sales Agreement by and between the Registrant and Cowen and Company, LLC, dated as of February 23, 2022 (Filed With SEC on February 23, 2022)
Description of Securities of the Registrant (Filed With SEC on February 23, 2022)
Second Amendment to Loan and Security Agreement, by and between the Registrant and Hercules Capital, Inc., dated November 1, 2021 (Filed With SEC on November 3, 2021)
Mutual Termination, Release, and Settlement Agreement by and between G1 Therapeutics, Inc. and Boehringer Ingelheim Pharmaceuticals, Inc., dated as of December 15, 2021 (Filed With SEC on February 23, 2022)
G1 Therapeutics, Inc. 2021 Sales Force Inducement Equity Incentive Plan (Filed With SEC on November 3, 2021)
Scientific, Clinical, and Regulatory Advisor Agreement by and between the Registrant and Seth A. Rudnick, MD, effective July 1, 2021 (Filed With SEC on August 4, 2021)
Employment Agreement by and between Registrant and Andrew Perry dated July 28, 2021 (Filed With SEC on August 4, 2021)
Second Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on June 21, 2021)
First Amendment to Loan and Security Agreement, by and between the Registrant and Hercules Capital, Inc., dated March 31, 2021 (Filed With SEC on May 5, 2021)
G1 Therapeutics, Inc. 2021 Inducement Equity Incentive Plan (Filed With SEC on February 24, 2021)
Description of Securities of the Registrant (Filed With SEC on February 24, 2021)
Senior Advisor Agreement between Registrant and Mark A. Velleca, M.D., Ph.D. dated September 29, 2020 (Filed With SEC on November 4, 2020)
Senior Advisor Agreement between Registrant and John E. Bailey, Jr. dated September 29, 2020 (Filed With SEC on November 4, 2020)
Employment Agreement by and between Registrant and John E. Bailey, Jr. dated September 29, 2020 (Filed With SEC on November 4, 2020)
Co-Promotion Agreement by and between the Registrant and Boehringer Ingelheim Pharmaceuticals, Inc., dated June 29, 2020 (Filed With SEC on August 5, 2020)
Loan and Security Agreement, by and between the Registrant and Hercules Capital, Inc., dated May 29, 2020 (Filed With SEC on August 5, 2020)
Scientific, Clinical, and Regulatory Advisor Agreement, by and between the Registrant and Seth A. Rudnick, M.D., effective July 1, 2020 (Filed With SEC on August 5, 2020)
Inducement Grant Option Agreement by and between the Registrant and Soma Gupta dated March 31, 2020 (Filed With SEC on May 6, 2020)
Employment Agreement by and between the Registrant and Soma Gupta dated March 12, 2020 (Filed With SEC on May 6, 2020)
Description of Securities of the Registrant (Filed With SEC on February 26, 2020)
Employment Agreement by and between the Registrant and Mark Avagliano, dated as of July 29, 2019 (Filed With SEC on August 7, 2019)
Separation and Transition Agreement by and between Registrant and Barclay Phillips, dated as of May 8, 2019 (Filed With SEC on August 7, 2019)
Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on June 13, 2019)
Employment Agreement, by and between the Registrant and Terry Murdock, dated as of August 1, 2017, as amended; filed as Exhibit 10.1 to the Registrants Quarterly Report on Form... (Filed With SEC on June 13, 2019)
Employment Agreement, by and between the Registrant and Rajesh K. Malik, M.D., dated July 1, 2014, as amended; First Amendment effective May 5, 2017, filed as Exhibit 10.5 to the... (Filed With SEC on June 13, 2019)
Amended and Restated Employment Agreement by and between the Registrant and Jennifer K. Moses dated May 8, 2019 (Filed With SEC on May 9, 2019)